Astaxanthin Ameliorates high-fat diet-induced cardiac damage and fibrosis by upregulating and activating SIRT1
Open Access
- 30 July 2021
- journal article
- research article
- Published by Elsevier in Saudi Journal of Biological Sciences
- Vol. 28 (12) , 7012-7021
Abstract
No abstract availableKeywords
Funding Information
- King Khalid University (R.G.P.1/228/41)
- Deanship of Scientific Research, King Faisal University
This publication has 53 references indexed in Scilit:
- Oxidative Stress in Cardiovascular Diseases and Obesity: Role of p66Shc and Protein Kinase COxidative Medicine and Cellular Longevity, 2013
- Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant miceCanadian Journal of Physiology and Pharmacology, 2012
- Interaction Between NFκB and NFAT Coordinates Cardiac Hypertrophy and Pathological RemodelingCirculation Research, 2012
- Astaxanthin in Cardiovascular Health and DiseaseMolecules, 2012
- Targeting Cardiovascular Disease With Novel SIRT1 PathwaysFuture Cardiology, 2011
- Effects of Astaxanthin on Oxidative Stress in Overweight and Obese AdultsPhytotherapy Research, 2011
- Astaxanthin: A Potential Therapeutic Agent in Cardiovascular DiseaseMarine Drugs, 2011
- Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humansNutrition & Metabolism, 2010
- Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cpLife Sciences, 2007
- Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax™)Life Sciences, 2004